AIHUA ZHANG: Open Payments
NPI 1467179895 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 33 payments from 19 companies in 2025. Trend: 2023 $662 · 2024 $759 · 2025 $879
Food & beverage: $786Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $165 |
| Syndax Pharmaceuticals, Inc. | 3 | $91 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Astellas Pharma US Inc | 3 | $61 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| Incyte Corporation | 2 | $51 |
| ABBVIE INC. | 2 | $46 |
| Celgene Corporation | 1 | $34 |
| SOBI, INC | 1 | $33 |
Products named: DARZALEX, OJJAARA, REBLOZYL, EPKINLY, TALVEY, CALQUENCE, Vonjo, RYBREVANT.
Industry payments across TX — which companies pay providers there.
